Apolipoprotein L1 Gene Effects on Kidney Transplantation

Academic Article

Abstract

  • © 2017 Elsevier Inc. The pathogenesis of many common etiologies of nephropathy has been informed by recent molecular genetic breakthroughs. It now is apparent that the ethnic disparity in the risk for nondiabetic chronic kidney disease between African Americans and European Americans is explained largely by variation in the apolipoprotein L1 gene (APOL1). The presence of two APOL1 renal risk variants markedly increases an individual's risk for kidney disease. In transplantation, kidneys from deceased African Americans with two APOL1 renal risk variants have shorter survival intervals after engraftment, regardless of the ethnicity of the recipient. Precision medicine will transform the clinical practice of nephrology and kidney transplantation, and play an important role in the allocation of kidneys from deceased and living kidney donors with recent African ancestry. This article reviews existing data on APOL1 in deceased-donor and living-donor kidney transplantation. It considers the impact of including APOL1 genotyping in decisions on the allocation and discard of deceased-donor kidneys, as well as the selection of living donors.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
  • Start Page

  • 530
  • End Page

  • 537
  • Volume

  • 37
  • Issue

  • 6